Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
MacroGenics announced updated Phase 2 TAMARACK study data for vobramitamab duocarmazine (vobra duo) in metastatic castration-resistant prostate cancer (mCRPC).
MacroGenics announced updated Phase 2 TAMARACK study data, showcasing vobramitamab duocarmazine's (vobra duo) encouraging antitumor activity in metastatic castration-resistant prostate cancer (mCRPC).
MacroGenics announced Phase 2 data for vobramitamab duocarmazine (vobra duo) in metastatic castration-resistant prostate cancer (mCRPC) at ESMO 2024.